Colleen Delaney

Colleen Delaney is a highly accomplished individual with a strong educational background and extensive experience in the field of medicine and biotechnology.

She pursued her Doctor of Medicine (M.D.) degree from Harvard Medical School, where she honed her skills and knowledge in the medical field.

Additionally, Colleen obtained a Bachelor of Arts (BA) in Molecular Biology and Biochemistry from Wesleyan University, further enhancing her expertise in the scientific domain.

Furthermore, she pursued a Master of Science (MSc) in Social Research and Social Policy from Oxford University, showcasing her multidisciplinary approach and interest in social aspects of research.

Colleen has been associated with prestigious organizations, serving as an Affiliate Investigator at Fred Hutch, highlighting her involvement in cutting-edge research initiatives.

She also played key roles at Deverra Therapeutics, where she founded the company and held positions as the Chief Scientific Officer and EVP of Research and Development, showcasing her leadership and strategic abilities.

Moreover, Colleen's contributions to Nohla Therapeutics as a Founder, Chief Scientific Officer, EVP of Research and Development, and Chief Medical Officer underline her versatile skill set and significant impact in the biotechnology sector.

Her involvement as a Full Member in the Clinical Research Division at Fred Hutch further demonstrates her commitment to advancing medical research and improving healthcare outcomes.